1: Zacarias O, Aguilar W, Paz MM, Tsukanov S, Zheng M, Cheng SY, Pradhan P, Champeil E. Isolation and Rationale for the Formation of Isomeric Decarbamoylmitomycin C- N(6)-deoxyadenosine Adducts in DNA. Chem Res Toxicol. 2018 Aug 20;31(8):762-771. doi: 10.1021/acs.chemrestox.8b00102. Epub 2018 Aug 2. PubMed PMID: 30035537.
2: Ahn K, O YM, Ji YG, Cho HJ, Lee DH. Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells. Yonsei Med J. 2018 Aug;59(6):727-735. doi: 10.3349/ymj.2018.59.6.727. PubMed PMID: 29978609; PubMed Central PMCID: PMC6037593.
3: Aguilar W, Paz MM, Vargas A, Zheng M, Cheng SY, Champeil E. Interdependent Sequence Selectivity and Diastereoselectivity in the Alkylation of DNA by Decarbamoylmitomycin C. Chemistry. 2018 Sep 6;24(50):13278-13289. doi: 10.1002/chem.201802038. Epub 2018 Aug 10. PubMed PMID: 29958326.
4: Aguilar W, Paz MM, Vargas A, Clement CC, Cheng SY, Champeil E. Sequence-Dependent Diastereospecific and Diastereodivergent Crosslinking of DNA by Decarbamoylmitomycin C. Chemistry. 2018 Apr 20;24(23):6030-6035. doi: 10.1002/chem.201705771. Epub 2018 Mar 27. PubMed PMID: 29504661.
5: Champeil E, Cheng SY, Huang BT, Conchero-Guisan M, Martinez T, Paz MM, Sapse AM. Synthesis of Mitomycin C and Decarbamoylmitomycin C N(2) deoxyguanosine-adducts. Bioorg Chem. 2016 Apr;65:90-9. doi: 10.1016/j.bioorg.2016.02.003. Epub 2016 Feb 11. PubMed PMID: 26894558; PubMed Central PMCID: PMC4807628.
6: Xiao G, Kue P, Bhosle R, Bargonetti J. Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction. Cell Cycle. 2015;14(5):744-54. doi: 10.1080/15384101.2014.997517. PubMed PMID: 25565400; PubMed Central PMCID: PMC4418290.
7: Hoffman S, Martin D, Meléndez A, Bargonetti J. C. elegans CEP-1/p53 and BEC-1 are involved in DNA repair. PLoS One. 2014 Feb 20;9(2):e88828. doi: 10.1371/journal.pone.0088828. eCollection 2014. PubMed PMID: 24586407; PubMed Central PMCID: PMC3930633.
8: Champeil E, Paz MM, Lukasiewicz E, Kong WS, Watson S, Sapse AM. Synthesis of a major mitomycin C DNA adduct via a triaminomitosene. Bioorg Med Chem Lett. 2012 Dec 1;22(23):7198-200. doi: 10.1016/j.bmcl.2012.09.052. Epub 2012 Sep 25. PubMed PMID: 23079525.
9: Boamah EK, Brekman A, Tomasz M, Myeku N, Figueiredo-Pereira M, Hunter S, Meyer J, Bhosle RC, Bargonetti J. DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1. Chem Res Toxicol. 2010 Jul 19;23(7):1151-62. doi: 10.1021/tx900420k. PubMed PMID: 20536192; PubMed Central PMCID: PMC2907727.
10: Paz MM, Ladwa S, Champeil E, Liu Y, Rockwell S, Boamah EK, Bargonetti J, Callahan J, Roach J, Tomasz M. Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry. Chem Res Toxicol. 2008 Dec;21(12):2370-8. doi: 10.1021/tx8002615. PubMed PMID: 19053323; PubMed Central PMCID: PMC2630229.
11: Boamah EK, White DE, Talbott KE, Arva NC, Berman D, Tomasz M, Bargonetti J. Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathways. ACS Chem Biol. 2007 Jun 15;2(6):399-407. Epub 2007 May 25. PubMed PMID: 17530733; PubMed Central PMCID: PMC2886584.
12: Palom Y, Suresh Kumar G, Tang LQ, Paz MM, Musser SM, Rockwell S, Tomasz M. Relative toxicities of DNA cross-links and monoadducts: new insights from studies of decarbamoyl mitomycin C and mitomycin C. Chem Res Toxicol. 2002 Nov;15(11):1398-406. PubMed PMID: 12437330.
13: Abbas T, Olivier M, Lopez J, Houser S, Xiao G, Kumar GS, Tomasz M, Bargonetti J. Differential activation of p53 by the various adducts of mitomycin C. J Biol Chem. 2002 Oct 25;277(43):40513-9. Epub 2002 Aug 14. PubMed PMID: 12183457.
14: Li VS, Tang MS, Kohn H. The effect of C(5) cytosine methylation at CpG sequences on mitomycin-DNA bonding profiles. Bioorg Med Chem. 2001 Apr;9(4):863-73. PubMed PMID: 11354669.
15: Li VS, Reed M, Zheng Y, Kohn H, Tang M. C5 cytosine methylation at CpG sites enhances sequence selectivity of mitomycin C-DNA bonding. Biochemistry. 2000 Mar 14;39(10):2612-8. PubMed PMID: 10704210.
16: Huh N, Rege AA, Yoo B, Kogan TP, Kohn H. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides. Bioconjug Chem. 1996 Nov-Dec;7(6):659-69. PubMed PMID: 8950485.
17: Kim SY, Rockwell S. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines. Oncol Res. 1995;7(5):39-47. PubMed PMID: 8534933.
18: Rockwell S, Kim SY. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines. Oncol Res. 1995;7(1):39-47. Corrected and republished in: Oncol Res. 1995;7(5):39-47. PubMed PMID: 7549043.
19: Basu AK, Hanrahan CJ, Malia SA, Kumar S, Bizanek R, Tomasz M. Effect of site-specifically located mitomycin C-DNA monoadducts on in vitro DNA synthesis by DNA polymerases. Biochemistry. 1993 May 11;32(18):4708-18. PubMed PMID: 8490017.
20: Tucker JD, Jones NJ, Allen NA, Minkler JL, Thompson LH, Carrano AV. Cytogenetic characterization of the ionizing radiation-sensitive Chinese hamster mutant irs1. Mutat Res. 1991 Mar;254(2):143-52. PubMed PMID: 1900570.